| [1] |
PERAZA A, GÓMEZ R, BELTRAN J, et al. Mucoepidermoid carcinoma. An update and review of the literature[J]. J Stomatol Oral Maxillofac Surg, 2020, 121(6): 713-720. DOI: 10.1016/j.jormas.2020.06.003. |
| [2] |
GUO XQ, LI B, LI Y, et al. Unusual mucoepidermoid carcinoma of the liver misdiagnosed as squamous cell carcinoma by intraoperative histological examination[J]. Diagn Pathol, 2014, 9: 24. DOI: 10.1186/1746-1596-9-24. |
| [3] |
JIANG Y, PENG ZW, YI SJ, et al. Argon-helium knife cryoablation in treatment of pulmonary mucoepidermoid carcinoma: A case report and literature review[J]. J Jilin Univ(Med Edit), 2022, 48(4): 1040-1044. DOI: 10.13481/j.1671-587X.20220426. |
| [4] |
PIANZOLA LE, DRUT R. Mucoepidermoid carcinoma of the liver[J]. Am J Clin Pathol, 1971, 56(6): 758-761. DOI: 10.1093/ajcp/56.6.758. |
| [5] |
HO JC. Two cases of mucoepidermoid carcinoma of the liver in Chinese[J]. Pathology, 1980, 12(1): 123-128. DOI: 10.3109/00313028009060061. |
| [6] |
|
| [7] |
|
| [8] |
LAMBRIANIDES AL, ASKEW AR, LEFEVRE I. Thorotrast-associated mucoepidermoid carcinoma of the liver[J]. Br J Radiol, 1986, 59(704): 791-792. DOI: 10.1259/0007-1285-59-704-791. |
| [9] |
HAYASHI I, TOMODA H, TANIMOTO M, et al. Mucoepidermoid carcinoma arising from a preexisting cyst of the liver[J]. J Surg Oncol, 1987, 36(2): 122-125. DOI: 10.1002/jso.2930360210. |
| [10] |
CHOI D, KIM H, LEE KS, et al. Mucoepidermoid carcinoma of the liver diagnosed as a liver abscess: report of a case[J]. Surg Today, 2004, 34(11): 968-972. DOI: 10.1007/s00595-004-2820-7. |
| [11] |
ARAKAWA Y, SHIMADA M, IKEGAMI T, et al. Mucoepidermoid carcinoma of the liver: report of a rare case and review of the literature[J]. Hepatol Res, 2008, 38(7): 736-742. DOI: 10.1111/j.1872-034X.2008.00335.x. |
| [12] |
WATANABE J, KAI K, TANIKAWA K, et al. Primary mucoepidermoid carcinoma of the liver with CRTC1-MAML2 fusion: a case report[J]. Diagn Pathol, 2019, 14(1): 84. DOI: 10.1186/s13000-019-0863-8. |
| [13] |
GOODE RK, AUCLAIR PL, ELLIS GL. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria[J]. Cancer, 1998, 82(7): 1217-1224. DOI: 10.1002/(sici)1097-0142(19980401)82:7<1217::aid-cncr2>3.0.co;2-c.
|
| [14] |
XU W, WANG Y, QI X, et al. Prognostic factors of palatal mucoepidermoid carcinoma: a retrospective analysis based on a double-center study[J]. Sci Rep, 2017, 7: 43907. DOI: 10.1038/srep43907. |
| [15] |
ZHANG D, LIAO X, TANG Y, et al. Warthin-like mucoepidermoid carcinoma of the parotid gland: unusual morphology and diagnostic pitfalls[J]. Anticancer Res, 2019, 39(6): 3213-3217. DOI: 10.21873/anticanres.13461. |
| [16] |
ISHIBASHI K, ITO Y, MASAKI A, et al. Warthin-like mucoepidermoid carcinoma: a combined study of fluorescence in situ hybridization and whole-slide imaging[J]. Am J Surg Pathol, 2015, 39(11): 1479-1487. DOI: 10.1097/PAS.0000000000000507. |
| [17] |
SONG TT, QIN MM, ZHAO YH, et al. Clinicopathological analysis of breast metastasis from mucoepidermoid carcinoma of the salivary gland[J]. Chin J Diagn Pathol, 2021, 28(8): 671-672, 677. DOI: 10.3969/j.issn.1007-8096.2021.08.015. |
| [18] |
KOMIYA T, PEREZ RP, YAMAMOTO S, et al. Primary lung mucoepidermoid carcinoma: analysis of prognostic factors using surveillance, epidemiology and end results program[J]. Clin Respir J, 2017, 11(6): 847-853. DOI: 10.1111/crj.12426. |
| [19] |
GRANIC M, SUTON P, MUELLER D, et al. Prognostic factors in head and neck mucoepidermoid carcinoma: experience at a single institution based on 64 consecutive patients over a 28-year period[J]. Int J Oral Maxillofac Surg, 2018, 47(3): 283-288. DOI: 10.1016/j.ijom.2017.09.005. |
| [20] |
GILL S, MOHAN A, AGGARWAL S, et al. Mucoepidermoid carcinoma of hard palate[J]. Indian J Pathol Microbiol, 2018, 61(3): 397-398. DOI: 10.4103/IJPM.IJPM_617_17. |
| [21] |
MILANOVIC D, JEREMIC B, KAYSER G, et al. Relapsing high grade mucoepidermoid carcinoma. Long-lasting complete response following reirradiation and EGFR blockade[J]. Strahlenther Onkol, 2012, 188(6): 518-522. DOI: 10.1007/s00066-012-0096-1. |
| [22] |
GHAZALI N, PARKER L, SETTLE K, et al. Sustained response of HER2-positive metastatic salivary adenocarcinoma, not otherwise specified, treated with trastuzumab[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2016, 122(3): 292-299. DOI: 10.1016/j.oooo.2016.03.020. |
| [23] |
de BLOCK K, VANDER POORTEN V, DORMAAR T, et al. Metastatic HER-2-positive salivary gland carcinoma treated with trastuzumab and a taxane: a series of six patients[J]. Acta Clin Belg, 2016, 71(6): 383-388. DOI: 10.1080/17843286.2016.1173940. |
| [24] |
CORRÊA TS, MATOS G, SEGURA M, et al. Second-line treatment of HER2-positive salivary gland tumor: ado-trastuzumab emtansine (T-DM1) after progression on trastuzumab[J]. Case Rep Oncol, 2018, 11(2): 252-257. DOI: 10.1159/000488669. |
DownLoad:
